Blood marker may predict deadly bleeding in Life-Support patients
NCT ID NCT07039513
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether changes in a blood marker called D-dimer can warn doctors about serious bleeding in patients on ECMO, a life-support machine for heart or lung failure. Researchers will track 100 intensive care patients and measure D-dimer levels over time. The goal is to find a threshold that signals high bleeding risk within the next 24 hours, which could help prevent complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict and prevent life-threatening bleeding in ECMO patients, making the treatment safer.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find a clear threshold, and results may not apply to all ECMO patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECMO are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Médecine Intensive - Réanimation Nouvel Hôpital Civil
Strasbourg, 67098, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less be more? testing transfusion limits in ECMO
- A short lesson before a tracheostomy may calm families' fears
- Dietitian study in ICU pulled before it started
- Can a pharmacy bundle shorten ICU stays and cut costs?
- New blood thinning combo could cut ECMO bleeding and clotting risks
- Can a pupil check predict brain recovery? new study tests Super-Early clues in ECMO patients